Piperidine-1-carbothioic acid (1-pyrazin-2-yl-ethylidene)-hydrazide

ID: ALA374548

PubChem CID: 9579564

Max Phase: Preclinical

Molecular Formula: C12H17N5S

Molecular Weight: 263.37

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C/C(=N\NC(=S)N1CCCCC1)c1cnccn1

Standard InChI:  InChI=1S/C12H17N5S/c1-10(11-9-13-5-6-14-11)15-16-12(18)17-7-3-2-4-8-17/h5-6,9H,2-4,7-8H2,1H3,(H,16,18)/b15-10+

Standard InChI Key:  IHPHTDJAZKAECG-XNTDXEJSSA-N

Molfile:  

     RDKit          2D

 18 19  0  0  0  0  0  0  0  0999 V2000
   -2.9345   -6.4035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9356   -7.2308    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2209   -7.6436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5045   -7.2303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5073   -6.3999    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2227   -5.9908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7894   -7.6416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7882   -8.4666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0757   -7.2281    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6393   -7.6394    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3531   -7.2258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0681   -7.6371    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3518   -6.4009    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.0656   -8.4626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7765   -8.8738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4928   -8.4638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4935   -7.6378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7779   -7.2221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  7  9  2  0
  4  5  1  0
  9 10  1  0
  2  3  1  0
 10 11  1  0
  5  6  2  0
 11 12  1  0
  6  1  1  0
 11 13  2  0
 12 14  1  0
  1  2  2  0
  4  7  1  0
  3  4  2  0
  7  8  1  0
 12 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
M  END

Associated Targets(Human)

HuT78 (515 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MT4 (17854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
41M (140 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 263.37Molecular Weight (Monoisotopic): 263.1205AlogP: 1.56#Rotatable Bonds: 2
Polar Surface Area: 53.41Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.78CX Basic pKa: 0.04CX LogP: 0.76CX LogD: 0.76
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.50Np Likeness Score: -1.87

References

1. Easmon J, Heinisch G, Holzer W, Rosenwirth B..  (1992)  Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents.,  35  (17): [PMID:1354751] [10.1021/jm00095a027]
2. Kowol CR, Berger R, Eichinger R, Roller A, Jakupec MA, Schmidt PP, Arion VB, Keppler BK..  (2007)  Gallium(III) and iron(III) complexes of alpha-N-heterocyclic thiosemicarbazones: synthesis, characterization, cytotoxicity, and interaction with ribonucleotide reductase.,  50  (6): [PMID:17315858] [10.1021/jm0612618]

Source